Search research articles
Contact Us
Filters
Showing results (51-60 of 221) with videos related to
Page
of 23
Sort By:
European Journal of Clinical Pharmacology
|
January 31, 2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
J J Vehreschild, C Müller, F Farowski, et al.
Annals of Hematology
|
November 28, 2017
Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M Schmidt-Hieber, J Bierwirth, D Buchheidt, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 6, 2014
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany
S M Heimann, M J G T Vehreschild, L Meintker, et al.
European Journal of Haematology
|
May 7, 2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients
Maria J G T Vehreschild, Michael von Bergwelt-Baildon, Liliane Tran, et al.
European Journal of Haematology
|
September 29, 2023
Torque teno virus-DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation
Arlene Spiertz, Anastasia Tsakmaklis, Fedja Farowski, et al.
Infection
|
December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort study
Johanna Kessel, Gesine Bug, Björn Steffen, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2023
[Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]
Andreas Stallmach, Lutz von Müller, Martin Storr, et al.
The Journal of Hospital Infection
|
November 14, 2018
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016
S M Heimann, M J G T Vehreschild, O A Cornely, et al.
Open Forum Infectious Diseases
|
November 15, 2019
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for <i>Clostridioides difficile</i> Infection in the EXTEND Study
Mark H Wilcox, Oliver A Cornely, Benoit Guery, et al.
European Journal of Haematology
|
October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation
Sebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 221) with videos related to
Sort By:
Page
of 23
European Journal of Clinical Pharmacology
|
January 31, 2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
J J Vehreschild, C Müller, F Farowski, et al.
Annals of Hematology
|
November 28, 2017
Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M Schmidt-Hieber, J Bierwirth, D Buchheidt, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 6, 2014
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany
S M Heimann, M J G T Vehreschild, L Meintker, et al.
European Journal of Haematology
|
May 7, 2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients
Maria J G T Vehreschild, Michael von Bergwelt-Baildon, Liliane Tran, et al.
European Journal of Haematology
|
September 29, 2023
Torque teno virus-DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation
Arlene Spiertz, Anastasia Tsakmaklis, Fedja Farowski, et al.
Infection
|
December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort study
Johanna Kessel, Gesine Bug, Björn Steffen, et al.
Zeitschrift Fur Gastroenterologie
|
May 15, 2023
[Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]
Andreas Stallmach, Lutz von Müller, Martin Storr, et al.
The Journal of Hospital Infection
|
November 14, 2018
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016
S M Heimann, M J G T Vehreschild, O A Cornely, et al.
Open Forum Infectious Diseases
|
November 15, 2019
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for <i>Clostridioides difficile</i> Infection in the EXTEND Study
Mark H Wilcox, Oliver A Cornely, Benoit Guery, et al.
European Journal of Haematology
|
October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation
Sebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Page
of 23